SCHEMBL7869460

SCHEMBL7869460

CCOCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCOC)nc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.43
P4HTM Q9NXG6 3/20 0.42
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GABRA5 P31644 2/20 0.40
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39
CA2 P00918 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
EPHX2 P34913 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9574842 1.00 EGFR (0.43) EGFRP4HTMHPGDSMN1; SMN2GABRA5
SCHEMBL7867703 0.97 EGFR (0.45) EGFRP4HTMHPGDSMN1; SMN2KMT2A
SCHEMBL7862739 0.95 HPGD (0.47) EGFRP4HTMHPGDSMN1; SMN2GABRA5
SCHEMBL7867912 0.94 EGFR (0.47) EGFRP4HTMHPGDSMN1; SMN2GABRA5
SCHEMBL7874534 0.94 EGFR (0.42) EGFRP4HTMHPGDSMN1; SMN2GABRA5
SCHEMBL7874619 0.94 HPGD (0.47) EGFRP4HTMHPGDSMN1; SMN2KMT2A
SCHEMBL7862692 0.93 EGFR (0.43) EGFRP4HTMHPGDSMN1; SMN2KMT2A
SCHEMBL7867827 0.93 KMT2A (0.42) EGFRP4HTMHPGDSMN1; SMN2KMT2A
SCHEMBL7871570 0.91 EGFR (0.45) EGFRP4HTMHPGDGABRA5KMT2A
SCHEMBL7871556 0.91 CA2 (0.47) EGFRHPGDSMN1; SMN2KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed